614 related articles for article (PubMed ID: 17900658)
21. Methylation of p15 and p16 genes in adult acute leukemia: lack of prognostic significance.
Chim CS; Tam CY; Liang R; Kwong YL
Cancer; 2001 Jun; 91(12):2222-9. PubMed ID: 11413509
[TBL] [Abstract][Full Text] [Related]
22. Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemia.
Omura-Minamisawa M; Diccianni MB; Batova A; Chang RC; Bridgeman LJ; Yu J; Pullen J; Bowman WP; Yu AL
Clin Cancer Res; 2000 Apr; 6(4):1219-28. PubMed ID: 10778944
[TBL] [Abstract][Full Text] [Related]
23. Hypermethylation of the p15(INK4B) gene in acute leukemia and myelodysplastic syndromes.
Chen H; Wu S
Chin Med J (Engl); 2002 Jul; 115(7):987-90. PubMed ID: 12150726
[TBL] [Abstract][Full Text] [Related]
24. Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients.
Wong IH; Lo YM; Yeo W; Lau WY; Johnson PJ
Clin Cancer Res; 2000 Sep; 6(9):3516-21. PubMed ID: 10999738
[TBL] [Abstract][Full Text] [Related]
25. Methylation status of the p15, p16 and MGMT promoter genes in primary cutaneous T-cell lymphomas.
Gallardo F; Esteller M; Pujol RM; Costa C; Estrach T; Servitje O
Haematologica; 2004 Nov; 89(11):1401-3. PubMed ID: 15531468
[TBL] [Abstract][Full Text] [Related]
26. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
Haviernik P; Schmidt M; Hu X; Wolff L
Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
[TBL] [Abstract][Full Text] [Related]
27. [Abnormal methylation of several tumor suppressor genes in sporadic breast cancer].
Zemliakova VV; Zhevlova AI; Strel'nikov VV; Liubchenko LN; Vishnevskaia IaV; Tret'iakova VA; Zaletaev DV; Nemtsova MV
Mol Biol (Mosk); 2003; 37(4):696-703. PubMed ID: 12942643
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic changes in tumor suppressor genes, P15, P16, APC-3 and E-cadherin in body fluid.
Chen ML; Chang JH; Yeh KT; Chang YS; Chang JG
Kaohsiung J Med Sci; 2007 Oct; 23(10):498-503. PubMed ID: 18055295
[TBL] [Abstract][Full Text] [Related]
29. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O
IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
[TBL] [Abstract][Full Text] [Related]
31. Inactivation of the p16 gene by hypermethylation and loss of heterozygosity in adenocarcinoma of the lung.
Awaya H; Takeshima Y; Amatya VJ; Furonaka O; Tagawa K; Kohno N; Inai K
Pathol Int; 2004 Jul; 54(7):486-9. PubMed ID: 15189501
[TBL] [Abstract][Full Text] [Related]
32. Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes.
Guney S; Jardin F; Bertrand P; Mareschal S; Parmentier F; Picquenot JM; Tilly H; Bastard C
Genes Chromosomes Cancer; 2012 Sep; 51(9):858-67. PubMed ID: 22619049
[TBL] [Abstract][Full Text] [Related]
33. Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia.
Scott SA; Kimura T; Dong WF; Ichinohasama R; Bergen S; Kerviche A; Sheridan D; DeCoteau JF
Leuk Res; 2004 Dec; 28(12):1293-301. PubMed ID: 15475071
[TBL] [Abstract][Full Text] [Related]
34. Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma.
Wang Y; Cheng J; Xu C; Liu S; Jiang S; Xu Q; Chen X; Zhuang H; Lu F
Liver Int; 2012 Mar; 32(3):420-8. PubMed ID: 22192146
[TBL] [Abstract][Full Text] [Related]
35. Gene methylation in pleural mesothelioma: correlations with clinico-pathological features and patient's follow-up.
Destro A; Ceresoli GL; Baryshnikova E; Garassino I; Zucali PA; De Vincenzo F; Bianchi P; Morenghi E; Testori A; Alloisio M; Santoro A; Roncalli M
Lung Cancer; 2008 Mar; 59(3):369-76. PubMed ID: 17920725
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic inactivation of the CIP/KIP cell-cycle control pathway in acute leukemias.
Chim CS; Wong AS; Kwong YL
Am J Hematol; 2005 Dec; 80(4):282-7. PubMed ID: 16315255
[TBL] [Abstract][Full Text] [Related]
37. In situ analysis of p16/INK4 promoter hypermethylation in esophageal carcinoma and gastric carcinoma.
Zhang F; Wang L; Wu PP; Yan ZW; Zheng L; Yu YY; Jiang XC
Chin J Dig Dis; 2004; 5(4):149-55. PubMed ID: 15612883
[TBL] [Abstract][Full Text] [Related]
38. Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma.
Furonaka O; Takeshima Y; Awaya H; Ishida H; Kohno N; Inai K
Pathol Int; 2004 Aug; 54(8):549-55. PubMed ID: 15260845
[TBL] [Abstract][Full Text] [Related]
39. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas.
Kirsch M; Mörz M; Pinzer T; Schackert HK; Schackert G
Genes Chromosomes Cancer; 2009 Feb; 48(2):143-54. PubMed ID: 18973139
[TBL] [Abstract][Full Text] [Related]
40. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia.
Batova A; Diccianni MB; Yu JC; Nobori T; Link MP; Pullen J; Yu AL
Cancer Res; 1997 Mar; 57(5):832-6. PubMed ID: 9041181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
